Synthetic Biology Market Size, Share, Trends, Growth, Production, Consumption, Revenue and Forecast 2020 - 2027

The global synthetic biology market size surpassed at US$ 4.90 Bn in 2019 and expected to reach US$ 39.5 billion by 2027 with a CAGR of 26.1% from 2020 to 2027. Rise in prevalence of chronic conditions, such as cancer and diabetes, has increased the patient pool, followed by rise in demand for biologic drugs for treating various chronic conditions, resulting in boosting the growth of the synthetic biology market.

In terms of product, the core product segment accounted for major share of the global synthetic biology market in 2019. The segment is anticipated to witness strong growth from 2020 to 2027.  The core product segment is further sub-segmented into synthetic DNA, synthetic genes, synthetic cells, XNA (xeno nucleic acid), and chassis organisms. The synthetic DNA sub-segment accounted for major share of the global synthetic biology market due to the increasing research & developmental activities associated to this sub-segment and increased penetration in the market.

  • The element that distinguishes synthetic biology from traditional molecular and cellular biology is the focus on the design and construction of core components (parts of enzymes, genetic circuits, and metabolic pathways) that can be understood, modeled, and tuned to meet specific performance criteria, and the assembly of these smaller parts and devices into bigger integrated systems for solving specific problems. These core components are formed through core products, such as synthetic genes and synthetic DNA.
  • According to an article published by Biotechnology Innovation Non-profit Organization, in 2010, scientists at the J. Craig Venter Institute (JCVI) announced the world’s first synthetic life form; the single-celled organism based on an existing bacterium that causes mastitis in goats, but at its core is an entirely synthetic genome that was constructed from three chemicals in the laboratory.
  • Increase in applications of core products has been observed recently. For instance, synthetic DNA is used to make proteins in living cells. Moreover, major applications of synthetic genes include synthesis of DNA sequences identified by high throughput sequencing.
  • All the factors mentioned above are responsible for driving the core product segment

Based on technology, the genome engineering segment held a major share in 2019 in synthetic biology market, due to its ability to make alterations to the genome of the living cell, and thereby gaining attention of the scientists and key players.  

  • Recent advances in genome engineering technology such as CRISPR-Cas9 have brought genome engineering to the forefront in the synthetic biology market
  • Zinc finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs) are also the advances which are responsible for genome editing and thereby have ameliorated the growth of the genetic engineering segment in the synthetic biology market

Based on application, the health care segment held a prominent share in 2019 in synthetic biology market due to increase in prevalence of various diseases, rise in key players, and expanding infrastructure as well as increasing focus of government in treatments and facilities in health care

  • According to Deloitte, with global health care spending expected to rise at a CAGR of 5% in 2019-2023, it will likely present many opportunities for the health care sector
  • Increase in geriatric population, rise in prevalence of chronic diseases, technological advancements, evolving care models, infrastructure investments, higher labor costs amidst workforce shortages, and expansion of health care systems in developing markets, are the factors responsible for the growth of the health care segment

Prominent Regions

North America held the largest share of the global synthetic biology market in 2018. North America accounted for significant share of the global synthetic biology market in 2019. The market in the region is likely to grow at a rapid pace during the forecast period.

  • The market in the region is driven by presence of key players, large number of research activities, and highly structured health care industry
  • Increase in investment by key players in North America and rise in prevalence of chronic diseases are projected to propel the synthetic biology market in North America

The U.S. is projected to dominate the synthetic biology market in the region during the forecast period, owing to early adoption of technologies. The country is anticipated to be the most attractive market for synthetic biology, with high attractiveness index.

  • Well-equipped hospitals, technological advancements, rise in research & development in synthetic biology for new applications, and surge in demand for novel products and treatments are projected to ameliorate the synthetic biology market in the U.S.

Key Players

  • Key players in the synthetic biology market focus on strengthening their positions in the global market 
  • Players are collaborating with other companies to secure and strengthen their positions in the synthetic biology market. For instance, in March 2018, Exxon Mobil Corporation and Synthetic Genomics Inc. announced a new phase in their joint algae biofuel research program that could lead to the technical ability to produce 10,000 barrels of algae biofuel per day by 2025.
  • In November 2018, Pivot Bio and Monsanto Company, a member of the Bayer Group, announced a collaboration for the development of Bradyrhizobium strains with enhanced nitrogen production for soybean growers in the U.S.
  • Major players operating in the global synthetic biology market include Evolva, Amyris, Algenol, ATG:biosynthetics GmbH, Bayer AG, Bristol-Myers Squibb Company, BIONEER CORPORATION, Biosearch Technologies, BASF SE, Codexis, Ginkgo Bioworks, Integrated DNA Technologies, Inc., GenScript, Thermo Fisher Scientific, Eurofins Genomics LLC, OriGene Technologies, Inc., and DSM

Market Segmentation

By Product

Core Product

Synthetic DNA
Synthetic Genes
Synthetic Cells
XNA (Xeno Nucleic Acid)
Chassis Organisms

Enabling Product

DNA Synthesis
Oligonucleotide Synthesis

By Technology
Genome Engineering
DNA Sequencing
Biological Components and Integrated Systems

By Application
Health Care
Chemicals (Including Biofuels)
Others (Biosecurity, R&D, Energy, and Environment)

By Region
North America
Asia Pacific
Latin America
Middle East & Africa

The report on the synthetic biology market studies past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market during the forecast period of 2020 to 2027. The report provides the overall market revenue of the synthetic biology market for the period of 2017–2027, with 2020 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for synthetic biology market during the forecast period.

The report is prepared after an extensive research. Primary research involves bulk of research efforts wherein, analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involves referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global synthetic biology market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomenon in the global synthetic biology market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on changing competitive dynamics in the global synthetic biology market. These indices serve as valuable tools for existing synthetic biology market players as well as for entities interested in entering the global synthetic biology market.

The report delves into the competition landscape of the global synthetic biology market. Key players operating in the global synthetic biology market are identified, and each one of them is profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOTs are some of the attributes of players in the global synthetic biology market that have been profiled in this report.

Key Questions Answered in the Synthetic Biology Market Report

  • What is the scope of growth of product companies in the synthetic biology sector?
  • What will be the Y-o-Y growth of the synthetic biology market between 2019 and 2027?
  • What is the influence of changing trends in Technology on the global synthetic biology market?
  • Will North America continue to remain the most profitable regional market for synthetic biology products providers?
  • Which factors will impede the growth of the global synthetic biology market during the forecast period?
  • Which are the leading companies in the global synthetic biology market?

Research Methodology

A unique research methodology has been utilized by TMR to conduct a comprehensive research on the growth of the global synthetic biology market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary sources referred to by analysts during the production of the global synthetic biology market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of VRR’s study on the synthetic biology market as primary sources.

These primary and secondary sources have provided exclusive information during interviews, which serves as a validation from synthetic biology market leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global synthetic biology market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and two bottom-up approaches to counter-validate them. This has helped in reaching VRR’s estimates on future prospects of the global synthetic biology market more reliably and accurately.

Report Detail

Proceed To Buy

USD 4500
USD 5000

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers